Fire Alarms Recalled Due to Hazardous Defect

Thousands of fire alarms sold on Amazon are recalled due to an audio defect that may fail during a fire. Owners should stop using them immediately.

Thousands of fire alarms with smoke detectors, sold exclusively on Amazon in the US, have been recalled due to an audio issue that could pose a fire hazard. The manufacturer identified a defect in the alarm signal that may not function properly in a critical situation. Owners of these devices are advised to immediately stop using them and contact the manufacturer for information on replacement. Home safety is a top priority, and it's important not to ignore such warnings.

Latest news

See all news

2026-02-16T17:15:12+00:00

Study Links Excessive Social Media Use to Loneliness Epidemic Among US Youth

A new study of nearly 65,000 students shows a direct link between time spent on social media and feelings of loneliness. The more hours young people spend on platforms each week, the higher their risk of feeling isolated and falling into depression. Researchers call for strengthening social connections and setting time limits for internet use.

Health Events Country

2026-02-14T04:25:45+00:00

9 Things Parents of Successful Children Do Differently

A study of over 200 parent-child relationships revealed that true success is not academic achievement, but self-confidence and emotional stability. Parents who understood this have adopted nine unconventional strategies that prioritize curiosity, a love of learning, and emotional intelligence over societal expectations.

Health Politics Country

2026-02-13T07:10:25+00:00

Trump Revokes Obama's Climate Finding

US President Donald Trump revoked a 2009 finding that six greenhouse gases from engines are harmful to health. Trump called this the biggest act of deregulation in U.S. history, citing lower costs for manufacturers and consumers.

Politics Economy Health Country

2026-02-13T04:26:11+00:00

Daniel O'Day of Gilead Sciences Named to TIME100 Health 2026 List

TIME magazine recognized Daniel O'Day, head of Gilead Sciences, for developing a semi-annual injectable HIV prevention drug that could be a game-changer for low- and middle-income countries.